Global Colloids (Blood Plasma) Supply, Demand and Key Producers, 2026-2032

January 2026 | 168 pages | ID: GF5CA97E4FA6EN
GlobalInfoResearch

US$ 4,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Colloids (Blood Plasma) market size is expected to reach $ 328 million by 2032, rising at a market growth of -2.4% CAGR during the forecast period (2026-2032).

Colloids (blood plasma) are the substances of expanding the circulating blood volume, which mainly contain albumin type, gelatin type, dextran type and hydroxyethyl starch type.

Colloids (Blood Plasma) can be applied for extensive burns, massive blood or plasma loss and hypovolemic shock. In this report, we calculate colloids (blood plasma) preparations, which is produced by albumin, gelatin, dextran and hydroxyethyl starch.

North America is the largest Colloids (Blood Plasma) market with about 33% market share. Europe is follower, accounting for about 28% market share.

The key players are CSL Behring, Baxter, Grifols, Octapharma, Kedrion, Shanghai Raas, CTBB, Hualan Bio, Rongsheng Pharmaceutical, Boya Rongsheng, B. Braun Medical, Fresenius Kabi, HOSPIRA, Axa parenterals, Fresenius Kabi(China), CR Double-Crane, Kelun Group, Shandong Qidu Pharmaceutical, Shandong Hualu Pharmaceutical, Minsheng Pharma, Kanglepharm etc. Top 3 companies occupied about 46% market share.

This report studies the global Colloids (Blood Plasma) production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Colloids (Blood Plasma) and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Colloids (Blood Plasma) that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Colloids (Blood Plasma) total production and demand, 2021-2032, (MT)
Global Colloids (Blood Plasma) total production value, 2021-2032, (USD Million)
Global Colloids (Blood Plasma) production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (MT), (based on production site)
Global Colloids (Blood Plasma) consumption by region & country, CAGR, 2021-2032 & (MT)
U.S. VS China: Colloids (Blood Plasma) domestic production, consumption, key domestic manufacturers and share
Global Colloids (Blood Plasma) production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (MT)
Global Colloids (Blood Plasma) production by Type, production, value, CAGR, 2021-2032, (USD Million) & (MT)
Global Colloids (Blood Plasma) production by Application, production, value, CAGR, 2021-2032, (USD Million) & (MT)

This report profiles key players in the global Colloids (Blood Plasma) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CSL Behring, Baxter, Grifols, Octapharma, Kedrion, Shanghai Raas, CTBB, Hualan Bio, Rongsheng Pharmaceutical, Boya Rongsheng, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Colloids (Blood Plasma) market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (MT) and average price (USD/Kg) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.

Global Colloids (Blood Plasma) Market, By Region:
  • United States
  • China
  • Europe
  • Japan
  • South Korea
  • ASEAN
  • India
  • Rest of World
Global Colloids (Blood Plasma) Market, Segmentation by Type:
  • Natural Type Colloids (Blood Plasma)
  • Synthetic Type Colloids (Blood Plasma)
Global Colloids (Blood Plasma) Market, Segmentation by Application:
  • Extensive Burns
  • Massive Blood or Plasma Loss
  • Hypovolemic Shock
  • Others
Companies Profiled:
  • CSL Behring
  • Baxter
  • Grifols
  • Octapharma
  • Kedrion
  • Shanghai Raas
  • CTBB
  • Hualan Bio
  • Rongsheng Pharmaceutical
  • Boya Rongsheng
  • B. Braun Medical
  • Fresenius Kabi
  • HOSPIRA
  • Axa parenterals
  • Fresenius Kabi (China)
  • CR Double-Crane
  • Kelun Group
  • Shandong Qidu Pharmaceutical
  • Shandong Hualu Pharmaceutical
  • Minsheng Pharma
  • Kanglepharm
Key Questions Answered:
1. How big is the global Colloids (Blood Plasma) market?
2. What is the demand of the global Colloids (Blood Plasma) market?
3. What is the year over year growth of the global Colloids (Blood Plasma) market?
4. What is the production and production value of the global Colloids (Blood Plasma) market?
5. Who are the key producers in the global Colloids (Blood Plasma) market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY

1.1 Colloids (Blood Plasma) Introduction
1.2 World Colloids (Blood Plasma) Supply & Forecast
  1.2.1 World Colloids (Blood Plasma) Production Value (2021 & 2025 & 2032)
  1.2.2 World Colloids (Blood Plasma) Production (2021-2032)
  1.2.3 World Colloids (Blood Plasma) Pricing Trends (2021-2032)
1.3 World Colloids (Blood Plasma) Production by Region (Based on Production Site)
  1.3.1 World Colloids (Blood Plasma) Production Value by Region (2021-2032)
  1.3.2 World Colloids (Blood Plasma) Production by Region (2021-2032)
  1.3.3 World Colloids (Blood Plasma) Average Price by Region (2021-2032)
  1.3.4 North America Colloids (Blood Plasma) Production (2021-2032)
  1.3.5 Europe Colloids (Blood Plasma) Production (2021-2032)
  1.3.6 China Colloids (Blood Plasma) Production (2021-2032)
  1.3.7 Japan Colloids (Blood Plasma) Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Colloids (Blood Plasma) Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Colloids (Blood Plasma) Major Market Trends

2 DEMAND SUMMARY

2.1 World Colloids (Blood Plasma) Demand (2021-2032)
2.2 World Colloids (Blood Plasma) Consumption by Region
  2.2.1 World Colloids (Blood Plasma) Consumption by Region (2021-2026)
  2.2.2 World Colloids (Blood Plasma) Consumption Forecast by Region (2027-2032)
2.3 United States Colloids (Blood Plasma) Consumption (2021-2032)
2.4 China Colloids (Blood Plasma) Consumption (2021-2032)
2.5 Europe Colloids (Blood Plasma) Consumption (2021-2032)
2.6 Japan Colloids (Blood Plasma) Consumption (2021-2032)
2.7 South Korea Colloids (Blood Plasma) Consumption (2021-2032)
2.8 ASEAN Colloids (Blood Plasma) Consumption (2021-2032)
2.9 India Colloids (Blood Plasma) Consumption (2021-2032)

3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS

3.1 World Colloids (Blood Plasma) Production Value by Manufacturer (2021-2026)
3.2 World Colloids (Blood Plasma) Production by Manufacturer (2021-2026)
3.3 World Colloids (Blood Plasma) Average Price by Manufacturer (2021-2026)
3.4 Colloids (Blood Plasma) Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
  3.5.1 Global Colloids (Blood Plasma) Industry Rank of Major Manufacturers
  3.5.2 Global Concentration Ratios (CR4) for Colloids (Blood Plasma) in 2025
  3.5.3 Global Concentration Ratios (CR8) for Colloids (Blood Plasma) in 2025
3.6 Colloids (Blood Plasma) Market: Overall Company Footprint Analysis
  3.6.1 Colloids (Blood Plasma) Market: Region Footprint
  3.6.2 Colloids (Blood Plasma) Market: Company Product Type Footprint
  3.6.3 Colloids (Blood Plasma) Market: Company Product Application Footprint
3.7 Competitive Environment
  3.7.1 Historical Structure of the Industry
  3.7.2 Barriers of Market Entry
  3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 UNITED STATES VS CHINA VS REST OF THE WORLD

4.1 United States VS China: Colloids (Blood Plasma) Production Value Comparison
  4.1.1 United States VS China: Colloids (Blood Plasma) Production Value Comparison (2021 & 2025 & 2032)
  4.1.2 United States VS China: Colloids (Blood Plasma) Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Colloids (Blood Plasma) Production Comparison
  4.2.1 United States VS China: Colloids (Blood Plasma) Production Comparison (2021 & 2025 & 2032)
  4.2.2 United States VS China: Colloids (Blood Plasma) Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Colloids (Blood Plasma) Consumption Comparison
  4.3.1 United States VS China: Colloids (Blood Plasma) Consumption Comparison (2021 & 2025 & 2032)
  4.3.2 United States VS China: Colloids (Blood Plasma) Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Colloids (Blood Plasma) Manufacturers and Market Share, 2021-2026
  4.4.1 United States Based Colloids (Blood Plasma) Manufacturers, Headquarters and Production Site (States, Country)
  4.4.2 United States Based Manufacturers Colloids (Blood Plasma) Production Value (2021-2026)
  4.4.3 United States Based Manufacturers Colloids (Blood Plasma) Production (2021-2026)
4.5 China Based Colloids (Blood Plasma) Manufacturers and Market Share
  4.5.1 China Based Colloids (Blood Plasma) Manufacturers, Headquarters and Production Site (Province, Country)
  4.5.2 China Based Manufacturers Colloids (Blood Plasma) Production Value (2021-2026)
  4.5.3 China Based Manufacturers Colloids (Blood Plasma) Production (2021-2026)
4.6 Rest of World Based Colloids (Blood Plasma) Manufacturers and Market Share, 2021-2026
  4.6.1 Rest of World Based Colloids (Blood Plasma) Manufacturers, Headquarters and Production Site (State, Country)
  4.6.2 Rest of World Based Manufacturers Colloids (Blood Plasma) Production Value (2021-2026)
  4.6.3 Rest of World Based Manufacturers Colloids (Blood Plasma) Production (2021-2026)

5 MARKET ANALYSIS BY TYPE

5.1 World Colloids (Blood Plasma) Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
  5.2.1 Natural Type Colloids (Blood Plasma)
  5.2.2 Synthetic Type Colloids (Blood Plasma)
5.3 Market Segment by Type
  5.3.1 World Colloids (Blood Plasma) Production by Type (2021-2032)
  5.3.2 World Colloids (Blood Plasma) Production Value by Type (2021-2032)
  5.3.3 World Colloids (Blood Plasma) Average Price by Type (2021-2032)

6 MARKET ANALYSIS BY APPLICATION

6.1 World Colloids (Blood Plasma) Market Size Overview by Application: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Application
  6.2.1 Extensive Burns
  6.2.2 Massive Blood or Plasma Loss
  6.2.3 Hypovolemic Shock
  6.2.4 Others
6.3 Market Segment by Application
  6.3.1 World Colloids (Blood Plasma) Production by Application (2021-2032)
  6.3.2 World Colloids (Blood Plasma) Production Value by Application (2021-2032)
  6.3.3 World Colloids (Blood Plasma) Average Price by Application (2021-2032)

7 COMPANY PROFILES

7.1 CSL Behring
  7.1.1 CSL Behring Details
  7.1.2 CSL Behring Major Business
  7.1.3 CSL Behring Colloids (Blood Plasma) Product and Services
  7.1.4 CSL Behring Colloids (Blood Plasma) Production, Price, Value, Gross Margin and Market Share (2021-2026)
  7.1.5 CSL Behring Recent Developments/Updates
  7.1.6 CSL Behring Competitive Strengths & Weaknesses
7.2 Baxter
  7.2.1 Baxter Details
  7.2.2 Baxter Major Business
  7.2.3 Baxter Colloids (Blood Plasma) Product and Services
  7.2.4 Baxter Colloids (Blood Plasma) Production, Price, Value, Gross Margin and Market Share (2021-2026)
  7.2.5 Baxter Recent Developments/Updates
  7.2.6 Baxter Competitive Strengths & Weaknesses
7.3 Grifols
  7.3.1 Grifols Details
  7.3.2 Grifols Major Business
  7.3.3 Grifols Colloids (Blood Plasma) Product and Services
  7.3.4 Grifols Colloids (Blood Plasma) Production, Price, Value, Gross Margin and Market Share (2021-2026)
  7.3.5 Grifols Recent Developments/Updates
  7.3.6 Grifols Competitive Strengths & Weaknesses
7.4 Octapharma
  7.4.1 Octapharma Details
  7.4.2 Octapharma Major Business
  7.4.3 Octapharma Colloids (Blood Plasma) Product and Services
  7.4.4 Octapharma Colloids (Blood Plasma) Production, Price, Value, Gross Margin and Market Share (2021-2026)
  7.4.5 Octapharma Recent Developments/Updates
  7.4.6 Octapharma Competitive Strengths & Weaknesses
7.5 Kedrion
  7.5.1 Kedrion Details
  7.5.2 Kedrion Major Business
  7.5.3 Kedrion Colloids (Blood Plasma) Product and Services
  7.5.4 Kedrion Colloids (Blood Plasma) Production, Price, Value, Gross Margin and Market Share (2021-2026)
  7.5.5 Kedrion Recent Developments/Updates
  7.5.6 Kedrion Competitive Strengths & Weaknesses
7.6 Shanghai Raas
  7.6.1 Shanghai Raas Details
  7.6.2 Shanghai Raas Major Business
  7.6.3 Shanghai Raas Colloids (Blood Plasma) Product and Services
  7.6.4 Shanghai Raas Colloids (Blood Plasma) Production, Price, Value, Gross Margin and Market Share (2021-2026)
  7.6.5 Shanghai Raas Recent Developments/Updates
  7.6.6 Shanghai Raas Competitive Strengths & Weaknesses
7.7 CTBB
  7.7.1 CTBB Details
  7.7.2 CTBB Major Business
  7.7.3 CTBB Colloids (Blood Plasma) Product and Services
  7.7.4 CTBB Colloids (Blood Plasma) Production, Price, Value, Gross Margin and Market Share (2021-2026)
  7.7.5 CTBB Recent Developments/Updates
  7.7.6 CTBB Competitive Strengths & Weaknesses
7.8 Hualan Bio
  7.8.1 Hualan Bio Details
  7.8.2 Hualan Bio Major Business
  7.8.3 Hualan Bio Colloids (Blood Plasma) Product and Services
  7.8.4 Hualan Bio Colloids (Blood Plasma) Production, Price, Value, Gross Margin and Market Share (2021-2026)
  7.8.5 Hualan Bio Recent Developments/Updates
  7.8.6 Hualan Bio Competitive Strengths & Weaknesses
7.9 Rongsheng Pharmaceutical
  7.9.1 Rongsheng Pharmaceutical Details
  7.9.2 Rongsheng Pharmaceutical Major Business
  7.9.3 Rongsheng Pharmaceutical Colloids (Blood Plasma) Product and Services
  7.9.4 Rongsheng Pharmaceutical Colloids (Blood Plasma) Production, Price, Value, Gross Margin and Market Share (2021-2026)
  7.9.5 Rongsheng Pharmaceutical Recent Developments/Updates
  7.9.6 Rongsheng Pharmaceutical Competitive Strengths & Weaknesses
7.10 Boya Rongsheng
  7.10.1 Boya Rongsheng Details
  7.10.2 Boya Rongsheng Major Business
  7.10.3 Boya Rongsheng Colloids (Blood Plasma) Product and Services
  7.10.4 Boya Rongsheng Colloids (Blood Plasma) Production, Price, Value, Gross Margin and Market Share (2021-2026)
  7.10.5 Boya Rongsheng Recent Developments/Updates
  7.10.6 Boya Rongsheng Competitive Strengths & Weaknesses
7.11 B. Braun Medical
  7.11.1 B. Braun Medical Details
  7.11.2 B. Braun Medical Major Business
  7.11.3 B. Braun Medical Colloids (Blood Plasma) Product and Services
  7.11.4 B. Braun Medical Colloids (Blood Plasma) Production, Price, Value, Gross Margin and Market Share (2021-2026)
  7.11.5 B. Braun Medical Recent Developments/Updates
  7.11.6 B. Braun Medical Competitive Strengths & Weaknesses
7.12 Fresenius Kabi
  7.12.1 Fresenius Kabi Details
  7.12.2 Fresenius Kabi Major Business
  7.12.3 Fresenius Kabi Colloids (Blood Plasma) Product and Services
  7.12.4 Fresenius Kabi Colloids (Blood Plasma) Production, Price, Value, Gross Margin and Market Share (2021-2026)
  7.12.5 Fresenius Kabi Recent Developments/Updates
  7.12.6 Fresenius Kabi Competitive Strengths & Weaknesses
7.13 HOSPIRA
  7.13.1 HOSPIRA Details
  7.13.2 HOSPIRA Major Business
  7.13.3 HOSPIRA Colloids (Blood Plasma) Product and Services
  7.13.4 HOSPIRA Colloids (Blood Plasma) Production, Price, Value, Gross Margin and Market Share (2021-2026)
  7.13.5 HOSPIRA Recent Developments/Updates
  7.13.6 HOSPIRA Competitive Strengths & Weaknesses
7.14 Axa parenterals
  7.14.1 Axa parenterals Details
  7.14.2 Axa parenterals Major Business
  7.14.3 Axa parenterals Colloids (Blood Plasma) Product and Services
  7.14.4 Axa parenterals Colloids (Blood Plasma) Production, Price, Value, Gross Margin and Market Share (2021-2026)
  7.14.5 Axa parenterals Recent Developments/Updates
  7.14.6 Axa parenterals Competitive Strengths & Weaknesses
7.15 Fresenius Kabi (China)
  7.15.1 Fresenius Kabi (China) Details
  7.15.2 Fresenius Kabi (China) Major Business
  7.15.3 Fresenius Kabi (China) Colloids (Blood Plasma) Product and Services
  7.15.4 Fresenius Kabi (China) Colloids (Blood Plasma) Production, Price, Value, Gross Margin and Market Share (2021-2026)
  7.15.5 Fresenius Kabi (China) Recent Developments/Updates
  7.15.6 Fresenius Kabi (China) Competitive Strengths & Weaknesses
7.16 CR Double-Crane
  7.16.1 CR Double-Crane Details
  7.16.2 CR Double-Crane Major Business
  7.16.3 CR Double-Crane Colloids (Blood Plasma) Product and Services
  7.16.4 CR Double-Crane Colloids (Blood Plasma) Production, Price, Value, Gross Margin and Market Share (2021-2026)
  7.16.5 CR Double-Crane Recent Developments/Updates
  7.16.6 CR Double-Crane Competitive Strengths & Weaknesses
7.17 Kelun Group
  7.17.1 Kelun Group Details
  7.17.2 Kelun Group Major Business
  7.17.3 Kelun Group Colloids (Blood Plasma) Product and Services
  7.17.4 Kelun Group Colloids (Blood Plasma) Production, Price, Value, Gross Margin and Market Share (2021-2026)
  7.17.5 Kelun Group Recent Developments/Updates
  7.17.6 Kelun Group Competitive Strengths & Weaknesses
7.18 Shandong Qidu Pharmaceutical
  7.18.1 Shandong Qidu Pharmaceutical Details
  7.18.2 Shandong Qidu Pharmaceutical Major Business
  7.18.3 Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Product and Services
  7.18.4 Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Production, Price, Value, Gross Margin and Market Share (2021-2026)
  7.18.5 Shandong Qidu Pharmaceutical Recent Developments/Updates
  7.18.6 Shandong Qidu Pharmaceutical Competitive Strengths & Weaknesses
7.19 Shandong Hualu Pharmaceutical
  7.19.1 Shandong Hualu Pharmaceutical Details
  7.19.2 Shandong Hualu Pharmaceutical Major Business
  7.19.3 Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Product and Services
  7.19.4 Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Production, Price, Value, Gross Margin and Market Share (2021-2026)
  7.19.5 Shandong Hualu Pharmaceutical Recent Developments/Updates
  7.19.6 Shandong Hualu Pharmaceutical Competitive Strengths & Weaknesses
7.20 Minsheng Pharma
  7.20.1 Minsheng Pharma Details
  7.20.2 Minsheng Pharma Major Business
  7.20.3 Minsheng Pharma Colloids (Blood Plasma) Product and Services
  7.20.4 Minsheng Pharma Colloids (Blood Plasma) Production, Price, Value, Gross Margin and Market Share (2021-2026)
  7.20.5 Minsheng Pharma Recent Developments/Updates
  7.20.6 Minsheng Pharma Competitive Strengths & Weaknesses
7.21 Kanglepharm
  7.21.1 Kanglepharm Details
  7.21.2 Kanglepharm Major Business
  7.21.3 Kanglepharm Colloids (Blood Plasma) Product and Services
  7.21.4 Kanglepharm Colloids (Blood Plasma) Production, Price, Value, Gross Margin and Market Share (2021-2026)
  7.21.5 Kanglepharm Recent Developments/Updates
  7.21.6 Kanglepharm Competitive Strengths & Weaknesses

8 INDUSTRY CHAIN ANALYSIS

8.1 Colloids (Blood Plasma) Industry Chain
8.2 Colloids (Blood Plasma) Upstream Analysis
  8.2.1 Colloids (Blood Plasma) Core Raw Materials
  8.2.2 Main Manufacturers of Colloids (Blood Plasma) Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Colloids (Blood Plasma) Production Mode
8.6 Colloids (Blood Plasma) Procurement Model
8.7 Colloids (Blood Plasma) Industry Sales Model and Sales Channels
  8.7.1 Colloids (Blood Plasma) Sales Model
  8.7.2 Colloids (Blood Plasma) Typical Distributors

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES

Table 1. World Colloids (Blood Plasma) Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Colloids (Blood Plasma) Production Value by Region (2021-2026) & (USD Million)
Table 3. World Colloids (Blood Plasma) Production Value by Region (2027-2032) & (USD Million)
Table 4. World Colloids (Blood Plasma) Production Value Market Share by Region (2021-2026)
Table 5. World Colloids (Blood Plasma) Production Value Market Share by Region (2027-2032)
Table 6. World Colloids (Blood Plasma) Production by Region (2021-2026) & (MT)
Table 7. World Colloids (Blood Plasma) Production by Region (2027-2032) & (MT)
Table 8. World Colloids (Blood Plasma) Production Market Share by Region (2021-2026)
Table 9. World Colloids (Blood Plasma) Production Market Share by Region (2027-2032)
Table 10. World Colloids (Blood Plasma) Average Price by Region (2021-2026) & (USD/Kg)
Table 11. World Colloids (Blood Plasma) Average Price by Region (2027-2032) & (USD/Kg)
Table 12. Colloids (Blood Plasma) Major Market Trends
Table 13. World Colloids (Blood Plasma) Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (MT)
Table 14. World Colloids (Blood Plasma) Consumption by Region (2021-2026) & (MT)
Table 15. World Colloids (Blood Plasma) Consumption Forecast by Region (2027-2032) & (MT)
Table 16. World Colloids (Blood Plasma) Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Colloids (Blood Plasma) Producers in 2025
Table 18. World Colloids (Blood Plasma) Production by Manufacturer (2021-2026) & (MT)
Table 19. Production Market Share of Key Colloids (Blood Plasma) Producers in 2025
Table 20. World Colloids (Blood Plasma) Average Price by Manufacturer (2021-2026) & (USD/Kg)
Table 21. Global Colloids (Blood Plasma) Company Evaluation Quadrant
Table 22. World Colloids (Blood Plasma) Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Colloids (Blood Plasma) Production Site of Key Manufacturer
Table 24. Colloids (Blood Plasma) Market: Company Product Type Footprint
Table 25. Colloids (Blood Plasma) Market: Company Product Application Footprint
Table 26. Colloids (Blood Plasma) Competitive Factors
Table 27. Colloids (Blood Plasma) New Entrant and Capacity Expansion Plans
Table 28. Colloids (Blood Plasma) Mergers & Acquisitions Activity
Table 29. United States VS China Colloids (Blood Plasma) Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Colloids (Blood Plasma) Production Comparison, (2021 & 2025 & 2032) & (MT)
Table 31. United States VS China Colloids (Blood Plasma) Consumption Comparison, (2021 & 2025 & 2032) & (MT)
Table 32. United States Based Colloids (Blood Plasma) Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Colloids (Blood Plasma) Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Colloids (Blood Plasma) Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Colloids (Blood Plasma) Production (2021-2026) & (MT)
Table 36. United States Based Manufacturers Colloids (Blood Plasma) Production Market Share (2021-2026)
Table 37. China Based Colloids (Blood Plasma) Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Colloids (Blood Plasma) Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Colloids (Blood Plasma) Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Colloids (Blood Plasma) Production, (2021-2026) & (MT)
Table 41. China Based Manufacturers Colloids (Blood Plasma) Production Market Share (2021-2026)
Table 42. Rest of World Based Colloids (Blood Plasma) Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Colloids (Blood Plasma) Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Colloids (Blood Plasma) Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Colloids (Blood Plasma) Production, (2021-2026) & (MT)
Table 46. Rest of World Based Manufacturers Colloids (Blood Plasma) Production Market Share (2021-2026)
Table 47. World Colloids (Blood Plasma) Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Colloids (Blood Plasma) Production by Type (2021-2026) & (MT)
Table 49. World Colloids (Blood Plasma) Production by Type (2027-2032) & (MT)
Table 50. World Colloids (Blood Plasma) Production Value by Type (2021-2026) & (USD Million)
Table 51. World Colloids (Blood Plasma) Production Value by Type (2027-2032) & (USD Million)
Table 52. World Colloids (Blood Plasma) Average Price by Type (2021-2026) & (USD/Kg)
Table 53. World Colloids (Blood Plasma) Average Price by Type (2027-2032) & (USD/Kg)
Table 54. World Colloids (Blood Plasma) Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 55. World Colloids (Blood Plasma) Production by Application (2021-2026) & (MT)
Table 56. World Colloids (Blood Plasma) Production by Application (2027-2032) & (MT)
Table 57. World Colloids (Blood Plasma) Production Value by Application (2021-2026) & (USD Million)
Table 58. World Colloids (Blood Plasma) Production Value by Application (2027-2032) & (USD Million)
Table 59. World Colloids (Blood Plasma) Average Price by Application (2021-2026) & (USD/Kg)
Table 60. World Colloids (Blood Plasma) Average Price by Application (2027-2032) & (USD/Kg)
Table 61. CSL Behring Basic Information, Manufacturing Base and Competitors
Table 62. CSL Behring Major Business
Table 63. CSL Behring Colloids (Blood Plasma) Product and Services
Table 64. CSL Behring Colloids (Blood Plasma) Production (MT), Price (USD/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. CSL Behring Recent Developments/Updates
Table 66. CSL Behring Competitive Strengths & Weaknesses
Table 67. Baxter Basic Information, Manufacturing Base and Competitors
Table 68. Baxter Major Business
Table 69. Baxter Colloids (Blood Plasma) Product and Services
Table 70. Baxter Colloids (Blood Plasma) Production (MT), Price (USD/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 71. Baxter Recent Developments/Updates
Table 72. Baxter Competitive Strengths & Weaknesses
Table 73. Grifols Basic Information, Manufacturing Base and Competitors
Table 74. Grifols Major Business
Table 75. Grifols Colloids (Blood Plasma) Product and Services
Table 76. Grifols Colloids (Blood Plasma) Production (MT), Price (USD/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 77. Grifols Recent Developments/Updates
Table 78. Grifols Competitive Strengths & Weaknesses
Table 79. Octapharma Basic Information, Manufacturing Base and Competitors
Table 80. Octapharma Major Business
Table 81. Octapharma Colloids (Blood Plasma) Product and Services
Table 82. Octapharma Colloids (Blood Plasma) Production (MT), Price (USD/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 83. Octapharma Recent Developments/Updates
Table 84. Octapharma Competitive Strengths & Weaknesses
Table 85. Kedrion Basic Information, Manufacturing Base and Competitors
Table 86. Kedrion Major Business
Table 87. Kedrion Colloids (Blood Plasma) Product and Services
Table 88. Kedrion Colloids (Blood Plasma) Production (MT), Price (USD/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 89. Kedrion Recent Developments/Updates
Table 90. Kedrion Competitive Strengths & Weaknesses
Table 91. Shanghai Raas Basic Information, Manufacturing Base and Competitors
Table 92. Shanghai Raas Major Business
Table 93. Shanghai Raas Colloids (Blood Plasma) Product and Services
Table 94. Shanghai Raas Colloids (Blood Plasma) Production (MT), Price (USD/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 95. Shanghai Raas Recent Developments/Updates
Table 96. Shanghai Raas Competitive Strengths & Weaknesses
Table 97. CTBB Basic Information, Manufacturing Base and Competitors
Table 98. CTBB Major Business
Table 99. CTBB Colloids (Blood Plasma) Product and Services
Table 100. CTBB Colloids (Blood Plasma) Production (MT), Price (USD/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 101. CTBB Recent Developments/Updates
Table 102. CTBB Competitive Strengths & Weaknesses
Table 103. Hualan Bio Basic Information, Manufacturing Base and Competitors
Table 104. Hualan Bio Major Business
Table 105. Hualan Bio Colloids (Blood Plasma) Product and Services
Table 106. Hualan Bio Colloids (Blood Plasma) Production (MT), Price (USD/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 107. Hualan Bio Recent Developments/Updates
Table 108. Hualan Bio Competitive Strengths & Weaknesses
Table 109. Rongsheng Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 110. Rongsheng Pharmaceutical Major Business
Table 111. Rongsheng Pharmaceutical Colloids (Blood Plasma) Product and Services
Table 112. Rongsheng Pharmaceutical Colloids (Blood Plasma) Production (MT), Price (USD/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 113. Rongsheng Pharmaceutical Recent Developments/Updates
Table 114. Rongsheng Pharmaceutical Competitive Strengths & Weaknesses
Table 115. Boya Rongsheng Basic Information, Manufacturing Base and Competitors
Table 116. Boya Rongsheng Major Business
Table 117. Boya Rongsheng Colloids (Blood Plasma) Product and Services
Table 118. Boya Rongsheng Colloids (Blood Plasma) Production (MT), Price (USD/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 119. Boya Rongsheng Recent Developments/Updates
Table 120. Boya Rongsheng Competitive Strengths & Weaknesses
Table 121. B. Braun Medical Basic Information, Manufacturing Base and Competitors
Table 122. B. Braun Medical Major Business
Table 123. B. Braun Medical Colloids (Blood Plasma) Product and Services
Table 124. B. Braun Medical Colloids (Blood Plasma) Production (MT), Price (USD/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 125. B. Braun Medical Recent Developments/Updates
Table 126. B. Braun Medical Competitive Strengths & Weaknesses
Table 127. Fresenius Kabi Basic Information, Manufacturing Base and Competitors
Table 128. Fresenius Kabi Major Business
Table 129. Fresenius Kabi Colloids (Blood Plasma) Product and Services
Table 130. Fresenius Kabi Colloids (Blood Plasma) Production (MT), Price (USD/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 131. Fresenius Kabi Recent Developments/Updates
Table 132. Fresenius Kabi Competitive Strengths & Weaknesses
Table 133. HOSPIRA Basic Information, Manufacturing Base and Competitors
Table 134. HOSPIRA Major Business
Table 135. HOSPIRA Colloids (Blood Plasma) Product and Services
Table 136. HOSPIRA Colloids (Blood Plasma) Production (MT), Price (USD/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 137. HOSPIRA Recent Developments/Updates
Table 138. HOSPIRA Competitive Strengths & Weaknesses
Table 139. Axa parenterals Basic Information, Manufacturing Base and Competitors
Table 140. Axa parenterals Major Business
Table 141. Axa parenterals Colloids (Blood Plasma) Product and Services
Table 142. Axa parenterals Colloids (Blood Plasma) Production (MT), Price (USD/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 143. Axa parenterals Recent Developments/Updates
Table 144. Axa parenterals Competitive Strengths & Weaknesses
Table 145. Fresenius Kabi (China) Basic Information, Manufacturing Base and Competitors
Table 146. Fresenius Kabi (China) Major Business
Table 147. Fresenius Kabi (China) Colloids (Blood Plasma) Product and Services
Table 148. Fresenius Kabi (China) Colloids (Blood Plasma) Production (MT), Price (USD/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 149. Fresenius Kabi (China) Recent Developments/Updates
Table 150. Fresenius Kabi (China) Competitive Strengths & Weaknesses
Table 151. CR Double-Crane Basic Information, Manufacturing Base and Competitors
Table 152. CR Double-Crane Major Business
Table 153. CR Double-Crane Colloids (Blood Plasma) Product and Services
Table 154. CR Double-Crane Colloids (Blood Plasma) Production (MT), Price (USD/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 155. CR Double-Crane Recent Developments/Updates
Table 156. CR Double-Crane Competitive Strengths & Weaknesses
Table 157. Kelun Group Basic Information, Manufacturing Base and Competitors
Table 158. Kelun Group Major Business
Table 159. Kelun Group Colloids (Blood Plasma) Product and Services
Table 160. Kelun Group Colloids (Blood Plasma) Production (MT), Price (USD/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 161. Kelun Group Recent Developments/Updates
Table 162. Kelun Group Competitive Strengths & Weaknesses
Table 163. Shandong Qidu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 164. Shandong Qidu Pharmaceutical Major Business
Table 165. Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Product and Services
Table 166. Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Production (MT), Price (USD/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 167. Shandong Qidu Pharmaceutical Recent Developments/Updates
Table 168. Shandong Qidu Pharmaceutical Competitive Strengths & Weaknesses
Table 169. Shandong Hualu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 170. Shandong Hualu Pharmaceutical Major Business
Table 171. Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Product and Services
Table 172. Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Production (MT), Price (USD/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 173. Shandong Hualu Pharmaceutical Recent Developments/Updates
Table 174. Shandong Hualu Pharmaceutical Competitive Strengths & Weaknesses
Table 175. Minsheng Pharma Basic Information, Manufacturing Base and Competitors
Table 176. Minsheng Pharma Major Business
Table 177. Minsheng Pharma Colloids (Blood Plasma) Product and Services
Table 178. Minsheng Pharma Colloids (Blood Plasma) Production (MT), Price (USD/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 179. Minsheng Pharma Recent Developments/Updates
Table 180. Minsheng Pharma Competitive Strengths & Weaknesses
Table 181. Kanglepharm Basic Information, Manufacturing Base and Competitors
Table 182. Kanglepharm Major Business
Table 183. Kanglepharm Colloids (Blood Plasma) Product and Services
Table 184. Kanglepharm Colloids (Blood Plasma) Production (MT), Price (USD/Kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 185. Kanglepharm Recent Developments/Updates
Table 186. Kanglepharm Competitive Strengths & Weaknesses
Table 187. Global Key Players of Colloids (Blood Plasma) Upstream (Raw Materials)
Table 188. Global Colloids (Blood Plasma) Typical Customers
Table 189. Colloids (Blood Plasma) Typical Distributors

LIST OF FIGURES

Figure 1. Colloids (Blood Plasma) Picture
Figure 2. World Colloids (Blood Plasma) Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Colloids (Blood Plasma) Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Colloids (Blood Plasma) Production (2021-2032) & (MT)
Figure 5. World Colloids (Blood Plasma) Average Price (2021-2032) & (USD/Kg)
Figure 6. World Colloids (Blood Plasma) Production Value Market Share by Region (2021-2032)
Figure 7. World Colloids (Blood Plasma) Production Market Share by Region (2021-2032)
Figure 8. North America Colloids (Blood Plasma) Production (2021-2032) & (MT)
Figure 9. Europe Colloids (Blood Plasma) Production (2021-2032) & (MT)
Figure 10. China Colloids (Blood Plasma) Production (2021-2032) & (MT)
Figure 11. Japan Colloids (Blood Plasma) Production (2021-2032) & (MT)
Figure 12. Colloids (Blood Plasma) Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Colloids (Blood Plasma) Consumption (2021-2032) & (MT)
Figure 15. World Colloids (Blood Plasma) Consumption Market Share by Region (2021-2032)
Figure 16. United States Colloids (Blood Plasma) Consumption (2021-2032) & (MT)
Figure 17. China Colloids (Blood Plasma) Consumption (2021-2032) & (MT)
Figure 18. Europe Colloids (Blood Plasma) Consumption (2021-2032) & (MT)
Figure 19. Japan Colloids (Blood Plasma) Consumption (2021-2032) & (MT)
Figure 20. South Korea Colloids (Blood Plasma) Consumption (2021-2032) & (MT)
Figure 21. ASEAN Colloids (Blood Plasma) Consumption (2021-2032) & (MT)
Figure 22. India Colloids (Blood Plasma) Consumption (2021-2032) & (MT)
Figure 23. Producer Shipments of Colloids (Blood Plasma) by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Colloids (Blood Plasma) Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Colloids (Blood Plasma) Markets in 2025
Figure 26. United States VS China: Colloids (Blood Plasma) Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Colloids (Blood Plasma) Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Colloids (Blood Plasma) Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Colloids (Blood Plasma) Production Market Share 2025
Figure 30. China Based Manufacturers Colloids (Blood Plasma) Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Colloids (Blood Plasma) Production Market Share 2025
Figure 32. World Colloids (Blood Plasma) Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Colloids (Blood Plasma) Production Value Market Share by Type in 2025
Figure 34. Natural Type Colloids (Blood Plasma)
Figure 35. Synthetic Type Colloids (Blood Plasma)
Figure 36. World Colloids (Blood Plasma) Production Market Share by Type (2021-2032)
Figure 37. World Colloids (Blood Plasma) Production Value Market Share by Type (2021-2032)
Figure 38. World Colloids (Blood Plasma) Average Price by Type (2021-2032) & (USD/Kg)
Figure 39. World Colloids (Blood Plasma) Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 40. World Colloids (Blood Plasma) Production Value Market Share by Application in 2025
Figure 41. Extensive Burns
Figure 42. Massive Blood or Plasma Loss
Figure 43. Hypovolemic Shock
Figure 44. Others
Figure 45. World Colloids (Blood Plasma) Production Market Share by Application (2021-2032)
Figure 46. World Colloids (Blood Plasma) Production Value Market Share by Application (2021-2032)
Figure 47. World Colloids (Blood Plasma) Average Price by Application (2021-2032) & (USD/Kg)
Figure 48. Colloids (Blood Plasma) Industry Chain
Figure 49. Colloids (Blood Plasma) Procurement Model
Figure 50. Colloids (Blood Plasma) Sales Model
Figure 51. Colloids (Blood Plasma) Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source


More Publications